Remote Assessment of Cognitive Function in Juvenile Neuronal Ceroid Lipofuscinosis (Batten disease)

Journal of Child Neurology

Volumn 31, Issue 4, 2016, Pages 481-487

  Ragbeer, Shayne N ^a   Augustine, Erika F ^a   Mink, Jonathan W ^a   Thatcher, Alyssa R ^a   Vierhile, Amy E ^a   Adams, Heather R ^a  

^a UNIVERSITY OF ROCHESTER   (United States)

Author keywords

Batten disease; CLN3; JNCL; neurodegenerative disease; telemedicine

Indexed keywords

ADOLESCENT; ARTICLE; AUDIOVISUAL EQUIPMENT; CHILD; CLINICAL ARTICLE; COGNITION ASSESSMENT; DEGENERATIVE DISEASE; FEASIBILITY STUDY; HUMAN; MALE; NEURONAL CEROID LIPOFUSCINOSIS; NEUROPSYCHOLOGICAL TEST; PILOT STUDY; PRIORITY JOURNAL; RELIABILITY; REMOTE SENSING; TELEMEDICINE; COGNITION; GENETICS; NEURONAL CEROID-LIPOFUSCINOSES; PROCEDURES; PSYCHOLOGY; REPRODUCIBILITY; TRAVEL;

CHAPERONE; CLN3 PROTEIN, HUMAN; MEMBRANE PROTEIN;

ADOLESCENT; CHILD; COGNITION; FEASIBILITY STUDIES; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MOLECULAR CHAPERONES; NEURONAL CEROID-LIPOFUSCINOSES; NEUROPSYCHOLOGICAL TESTS; PILOT PROJECTS; REPRODUCIBILITY OF RESULTS; TELEMEDICINE; TRAVEL;

EID: 84957941928     PISSN: 08830738     EISSN: 17088283     Source Type: Journal    
DOI: 10.1177/0883073815600863     Document Type: Article

References (39)

1. Phillips SN, Benedict JW, Weimer JM, Pearce DA,. CLN3, the protein associated with batten disease: structure, function and localization. J Neurosci Res. 2005; 79: 573-583.
2. Williams R, Mole S,. New nomenclature and classification scheme for the neuronal ceroid lipofuscinoses. Neurology. 2012; 79: 183-191.
3. Williams R,. NCL incidence and prevalence data. In: Mole S, Williams R, Goebel H, eds. The Neuronal Ceroid Lipofuscinoses: Batten Disease. ed. Oxford: Oxford University Press; 2011.
4. de Blieck E, Augustine E, Marshall F, et al. Methodology of clinical research in rare diseases: development of a research program in juvenile neuronal ceroid lipofuscinosis (JNCL) via creation of a patient registry and collaboration with patient advocates. Contemp Clin Trials. 2013; 35: 48-54.
5. Chen T, Yang Y, Mai H, et al. Reliability and validity of outcome measures of in-hospital and at-home visits in a randomized, double-blind, placebo-controlled trial for spinal muscular atrophy. J Child Neurol. 2014; 29: 1680-1684.
6. Shire Website. Rare disease impact report: insights from patients and the medical community. http://www.shire.com/shireplc/dlibrary/documents/RareDiseaseImpactReportforWeb.pdf. Published April 9, 2013. Accessed May 22, 2015.
7. Walsh S, Raman R, Jones K, Aisen P, for the Alzheimer's Disease Cooperative Study Group. ADCS prevention instrument project: The Mail-In Cognitive Function Screening Instrument (MCFSI). Alz Dis Assoc Dis. 2006; 20: S170-S178.
8. Castanho T, Amorim L, Zihl J, Palha J, Sousa N, Santos N,. Telephone-based screening tools for mild cognitive impairment and dementia in aging studies: a review of validated instruments. Front Aging Neurosci. 2014; 25: 16.
9. Kent J, Plomin R,. Testing specific cognitive abilities by telephone and mail. Intelligence. 1987; 11: 391-400.
10. Petrill S, Rempell J, Oliver B, Plomin R,. Testing cognitive abilities by telephone in a sample of 6- to 8-year olds. Intelligence. 2002; 30: 353-360.
11. Dale P, Harlaar N, Plomin R,. Telephone testing and teacher assessment of reading skills in 7-year olds: substantial correspondence for a sample of 5544 children and for extremes. Read Writ. 2005; 18: 385-400.
12. United States Census Bureau. Computer and Internet Access in the United States: 1984-2012. http://www.census.gov/hhes/computer/publications/2012.html. Published February 3, 2014. Accessed May 22, 2015.
13. Cialone J, Augustine EF, Newhouse N, Vierhile A, Marshall FJ, Mink JW,. Quantitative telemedicine ratings in Batten disease: implications for rare disease research. Neurology. 2011; 77: 1808-1811.
14. Psychological Corporation. Wechsler Intelligence Scale for Children-Fourth Edition. Manual. San Antonio, TX: The Psychological Corporation; 2003.
15. Sheslow D, Adams W,. WRAML2. Wide Range Assessment of Memory and Learning. 2nd ed. Wilmington, DE: Wide Range, Inc; 2003.
16. Adams H, Mink J, and the University of Rochester Batten Center Study Group. Neurobehavioral Features and Natural History of Juvenile Neuronal Ceroid Lipofuscinosis (Batten Disease). J Child Neurol. 2013; 28: 1128-1136.
17. Statistica [computer program]. Version 12. Tulsa, OK: Statsoft, Inc.; 2013.
18. United States Department of Transportation, Bureau of Transportation Statistics. Average domestic air fares. https://www.rita.dot.gov/bts/airfares/compare/airports-metropolitan-areas/results/ROC/None/None. Accessed June 6, 2015.
19. Loh P, Donaldson M, Flicker L, Maher S, Goldswain P,. Development of a telemedicine protocol for the diagnosis of Alzheimer's disease. J Telemed Telecare. 2007; 13: 90-94.
20. Loh P, Ramesh P, Maher S, Salgari J, Flicker L, Goldswain P,. Can patients with dementia be assessed at a distance? The use of telehealth and standardised assessments. Internal Med J. 2004; 34: 239-242.
21. Shores M, Ryan-Dykes P, Williams R, et al. Identifying undiagnosed dementia in residential care veterans: comparing telemedicine to in-person clinical examination. Int J Geriatr Psych. 2004; 19: 101-108.
22. Ciemins E, Holloway B, Coon P, McClosky-Armstrong T, Min S,. Telemedicine and the Mini-Mental State Examination: assessment from a distance. Telemed J E-Health. 2009; 15: 476-478.
23. Fong T, Fearing M, Jones R, et al. Telephone interview for cognitive status: creating a crosswalk with the Mini-Mental State Examination. Alzheimers Dement. 2009; 5: 492-497.
24. Dorsey E, Voss T, Shprecher D, et al. A U.S. survey of patients with Parkinson's disease: satisfaction with medical care and support groups. Mov Disorder. 2010; 25: 2128-2135.
25. Langkamp D, McManus M, Blakemore S,. Telemedicine for children with developmental disabilities: a more effective clinical process than office-based care. Telemed J E-Health. 2014; 21: 110-114.
26. Temple V, Drummond C, Valiquette S, Jozsvai E,. A comparison of intellectual assessments over video conferencing and in-person for individuals with ID: preliminary data. J Intell Disabil Res. 2010; 54: 573-577.
27. Waite M, Theodoros D, Russell T, Cahill L,. Assessment of children's literacy via an Internet-based telehealth system. Telemed J E-Health. 2010; 16: 564-575.
28. Waite M, Theodoros D, Russell T, Cahill L,. Internet-based telehealth assessment of language using the CELF-4. Lang Speech Hear Ser. 2010; 41: 445-458.
29. Lezak M, Howieson D, Bigler E, Tranel D,. Neuropsychological Assessment. 5th ed. New York: Oxford University Press; 2012.
30. Adams H,. Remote technology to expand the research of clinical research. United States Food and Drug Administration. Paper presented at Public Workshop on Assessment of Neurocognitive Outcomes in Inborn Errors of Metabolism and Advancing the Development of Pediatric Therapeutics: Assessment of Neurocognitive Outcomes; April 16-17, 2015; Silver Spring, Maryland. Transcript of the meeting Available at: http://www.fda.gov/downloads/Drugs/NewsEvents/UCM449489.pdf. Accessed June 6, 2015.
31. Ben-Zeev D, Scherer E, Wang R, Xie H, Campbell A,. Next-generation psychiatric assessment: using smartphone sensors to monitor behavior and mental health. Psychiatr Rehabil J. Epub 7 Apr 2015.
32. Nelson EL, Bui TN, Velasquez SE,. Telepsychology: research and practice overview. Child Adolesc Psychiatr Clin N Am. 2011; 20: 67-79.
33. Diamond JM, Bloch RM,. Telepsychiatry assessments of child or adolescent behavior disorders: a review of evidence and issues. Telemed J E-Health. 2010; 16: 712-716.
34. Dorsey ER, Venuto C, Venkataraman V, Harris DA, Kieburtz K,. Novel methods and technologies for 21st-century clinical trials: a review. JAMA Neurol. 2015; 72: 582-588.
35. Adams H, de Blieck EA, Mink JW, et al. Standardized assessment of behavior and adaptive living skills in juvenile neuronal ceroid lipofuscinosis. Dev Med Child Neurol. 2006; 48: 259-264.
36. Kobak K, Engelhardt N, JBW W, Lipsitz J,. Rater training in multicenter clinical trials: issues and recommendations. J Clin Psychopharmacol. 2004; 24: 113-117.
37. Kobak K, Kane J, Thase M, Nierenberg A,. Why do clinical trials fail? the problem of measurement error in clinical trials: time to test new paradigms? J Clin Pharmacol. 2007; 27: 1-5.
38. Luxton D, Pruitt L, Osenbach J,. Best practices for remote psychological assessment via telehealth technologies. Professional Psychol. 2014; 45: 27-35.
39. Achey M, Beck C, Beran D, et al. Virtual house calls for Parkinson disease (Connect.Parkinson): study protocol for a randomized, controlled trial. Trials. 2014; 15: 465.